Shana Kelley

There were also some very, very talented engineers and chemists on the team that could make it happen and had the skills to put it all together.

But I think it's also, you know, being in the space for a while, also straddling the research world and the commercial world and kind of knowing what the unmet needs are in the industry and just understanding those big problems.

And I think from what I've said, I'm just kind of a problem person.

I'm not somebody who's like a basic science person.

I have incredible respect for people that just go super deep with a basic science problem.

But for me, it's much more about the application and what is impossible right now that we could make possible.

And going after those kinds of problems, to me, that's why being a scientist is just so awesome.

I mean, I love this path of discovery and then attacking, you know, hard problems that could have a major impact.

Yeah, we have been the group that's been most active on protein sensing.

There is also some wonderful work on developing sensors for other small molecules, kind of way beyond glucose.

So there's

Kevin Plaxco at UCSB, there's Tom So at Stanford, Jason Heichenfeld in Cincinnati, a lot of people that are taking sensors for small molecules, using them to look at drugs being metabolized in the bloodstream, looking at various things that will also, I think, be really powerful as clinical tools.

So

We've just stayed over on the protein side of things because I just historically, you know, have looked at chronic disease management and how difficult it is and the need for other tools.

But we're certainly not alone in terms of a keen interest in developing electrochemical sensors and really believing that, like, the CGM-like paradigm is the way we're going to get there.

That's what we're aiming for.

This is being recorded, Eric, so we'll take you up on that.

Yeah, absolutely.

I mean, right now we are focused on systemic inflammation.

So if whatever markers, you know, give you the right output end up in the interstitial fluid, we can get at that.